Recruiting

NCT Number: NCT06524843

Fracture Risk Evaluation of Bone Metastases Derived From Carcinoma

From the archives of the Rizzoli institute all patients (approximately 750) treated for bone metastases from 01/01/2010 to 31/12/2022.

A review will be made from the medical records, radiological imaging, and histological data of these patients

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Bone Metastases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

IRCCS Istituto Ortopedico Rizzoli

Bologna, Emilia-Romagna, 40134, Italy

Location status: Recruiting

Location contact

Costantino Errani, MD

CONTACT

[email protected]

0516366 ext. 103

Roberta Laranga, PhD

CONTACT

[email protected]

051636 ext. 5123

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Age ≥ 18 years
Diagnosis of bone metastasis from carcinoma, regardless of the type of carcinoma, and of the number and location of the metastases
Availability of imaging and clinical data
Availability of at least one follow-up during the last 12 months form diagnosis

Exclusion criteria

At least one inclusion creteria not met

Treatment and study plan

Analysis

Other

Analysis and review of imaging and clinical data

Primary outcomes

Creation a dataset of clinical data and diagnostic images

Time frame: At baseline (Day 0)

Creation a dataset of clinical data and diagnostic images, called RAW, relating to patients suffering from metastatic bone cancer that will be used by the unit UNICH to create innovative models for fracture risk prediction and of life expectancy based on various patient clinical parameters.

Study contacts

Contact information is provided by the study sponsor or research team.

Costantino Errani, MD

CONTACT

[email protected]

0516366 ext. 103

Roberta Laranga, PhD

CONTACT

[email protected]

051636 ext. 5123

Sponsors and collaborators

Lead sponsor

Costantino Errani

Other

Registry information

Official study title

Generation of Synthetic Patient Data (RAW) for Risk Evaluation of Bone Metastases Derived From Carcinoma

Important dates

Study start: 2024
Primary completion: 2026
Study completion: 2026
First posted: Jul 29, 2024
Registry last updated: Dec 15, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Recruiting